Device / Technology News RSS Feed - Device / Technology News

Cook Medical's Instinct Endoscopic Hemoclip now available to gastroenterologists

Cook Medical's Instinct Endoscopic Hemoclip now available to gastroenterologists

The Instinct Endoscopic Hemoclip is now available to gastroenterologists in major global markets. The clip is used to stop gastrointestinal (GI) tract bleeding, which is a condition that can be challenging to treat because of the variations among bleeds. [More]
Liaison Healthcare's EMR-Link solution recognized as a certified Health IT Quality Solution

Liaison Healthcare's EMR-Link solution recognized as a certified Health IT Quality Solution

As a certified Health IT Quality Solution, Liaison Healthcare's EMR-Link solution has been recognized by Quest Diagnostics as meeting or exceeding advanced industry standards for health IT quality and for providing a streamlined, interoperable solution that enables secure clinical laboratory ordering and results reporting through Quest Diagnostics connectivity solutions. [More]
WLSA's Convergence Summit to focus on global adoption of technology-enabled health care

WLSA's Convergence Summit to focus on global adoption of technology-enabled health care

The Wireless-Life Sciences Alliance said today that its ninth annual Convergence Summit here next month will focus on achieving broader global adoption of technology-enabled health care at a time when the pace of innovation in connected health and personal health solutions is accelerating. [More]

Engineering students create wearable treatment for infant jaundice

Around 60 percent of infants are born jaundiced and many spend their first days of life isolated underneath special lights that help them eliminate the excess bilirubin in their bloodstreams. [More]
NovaBay introduces new eye care product to help patients with eyelids irritation

NovaBay introduces new eye care product to help patients with eyelids irritation

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced that it is introducing a new eye care product, i-Lid Cleanser. [More]
Nuvo Research collaborates with Ferndale to develop 2 topical dermatology products

Nuvo Research collaborates with Ferndale to develop 2 topical dermatology products

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced a collaboration involving Ferndale Laboratories, Inc. and a leading Contract Research Organization with significant dermatology experience to develop two topical dermatology products based on Nuvo's patented Multiplexed Molecular Penetration Enhancer technology. [More]

American Health Network live using eClinicalWorks CCMR for population health management

eClinicalWorks®, a leader in ambulatory healthcare IT solutions, today announced American Health Network (AHN) is live using eClinicalWorks Care Coordination Medical Record® (CCMR) for population health management to manage three Accountable Care Organizations (ACOs) - American Health Network of Ohio Care Organization, Franciscan AHN ACO and Indiana Care Organization. [More]
New tool can help doctors identify patients at highest risk for respiratory failure after surgery

New tool can help doctors identify patients at highest risk for respiratory failure after surgery

A new prediction tool can help doctors better identify patients who are at highest risk for respiratory failure after surgery and therefore prevent the often deadly condition, suggest data from a large multi-center study published in the May issue of Anesthesiology. [More]
Scientists develop DNA nanodevices that survive body's immune defenses

Scientists develop DNA nanodevices that survive body's immune defenses

It's a familiar trope in science fiction: In enemy territory, activate your cloaking device. And real-world viruses use similar tactics to make themselves invisible to the immune system. [More]
Communication scholars to discuss the impact of technology at ICA conference

Communication scholars to discuss the impact of technology at ICA conference

The International Communication Association will hold its 64th annual conference, May 22-26 in Seattle, Washington. The theme of the 2014 conference will explore what the "good life" means in a networked and digital society. [More]
Researchers develop first size-based form of chromatography using nanodot technology

Researchers develop first size-based form of chromatography using nanodot technology

Using nanodot technology, Berkeley Lab researchers have demonstrated the first size-based form of chromatography that can be used to study the membranes of living cells. [More]

New data-based model accurately estimates hemoglobin A1c using SMBG readings

Hemoglobin A1c is the standard measurement for assessing glycemic control over time in people with diabetes. [More]
Anxiety experienced with false-positive mammogram does not negatively impact woman's well-being

Anxiety experienced with false-positive mammogram does not negatively impact woman's well-being

Dartmouth researchers have found that the anxiety experienced with a false-positive mammogram is temporary and does not negatively impact a woman's overall well-being. Their findings are reported in "Consequences of False-Positive Screening Mammograms," which was published online in the April 21, 2014 JAMA Internal Medicine. [More]

Symposium focused on Surefire Medical's COSY clinical trial to be held at ECIO meeting

Surefire Medical, Inc. announced that a symposium focused on the Coiling vs. Surefire Infusion System in Y90 (COSY) clinical trial will be held during the European Conference on Interventional Oncology (ECIO) meeting taking place in Berlin, Germany April 23-26. T [More]

VHVI implants miniaturized HeartWare HVAD Pump through minimally invasive approach

Sometimes smaller is better. This is especially true of left ventricular assist devices, the mechanically operated heart pumps that are implanted in heart failure patients to bridge them to transplantation. [More]

Avedro receives Canadian approval for KXL II System

Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes. [More]
Rhenovia Pharma's SMARTT e-Patch project wins award at the French ‘World Innovation Challenge'

Rhenovia Pharma's SMARTT e-Patch project wins award at the French ‘World Innovation Challenge'

Rhenovia Pharma, a biotechnology company specialized in the application of biosimulation to the research and development of new medicinal products, today announces that its SMARTT e-Patch project has won an award at the ‘World Innovation Challenge’; founded by the President of France to identify future champions in the French economy. [More]

OGT releases new application note detailing performance of two DNA labelling kits

Oxford Gene Technology, The Molecular Genetics Company, has released a new application note detailing the technical evaluation of two DNA labelling kits, where OGT’s CytoSure Genomic DNA Labelling Kits were found to be quicker and more accurate than a leading alternative. [More]

Spire Leeds Hospital invests £200,000 in PENTAX Medical’s HD+ endoscopes

Spire Leeds Hospital has invested almost £200,000 in state-of-the-art endoscopy equipment from PENTAX Medical – which will benefit local patients. The extraordinarily high resolution images that the new equipment provides will help enhance the hospital’s detection of diseases, such as cancer, and enable earlier treatment which can improve patient outcomes. [More]
New FDA-approved device reduces seizures in patients with medication-resistant epilepsy

New FDA-approved device reduces seizures in patients with medication-resistant epilepsy

A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials. [More]